Join this ECHO Lessons from Leaders webinar, featuring Dr. Lucy O’Keeffe (CEO & Co-Founder of CroíValve), who will share an overview of CroíValve, its technologies, and the story behind its success. CroíValve is a clinical stage medical device company developing a novel transcatheter device to treat tricuspid regurgitation, which is a severe heart condition that occurs when the tricuspid valve in the heart fails to close properly, resulting in blood being pumped backwards into the heart and causing debilitating symptoms. Their DUO System is a minimally invasive, coaptation heart valve device that repairs the tricuspid valve without the need for surgery. CroíValve’s Research, Development, and Operations are based in Ireland and their Clinical and Regulatory are based in the United States.